Galcanezumab
Showing 1 - 25 of 35
Migraine Trial in San Francisco (Galcanezumab)
Recruiting
- Migraine
- Galcanezumab
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 10, 2023
Migraine Trial (Galcanezumab, Placebo)
Not yet recruiting
- Migraine
- Galcanezumab
- Placebo
- (no location specified)
Aug 5, 2022
Vestibular Migraine Trial in San Francisco (Galcanezumab Prefilled Syringe, Placebo)
Recruiting
- Vestibular Migraine
- Galcanezumab Prefilled Syringe
- Placebo
-
San Francisco, CaliforniaUCSF Medical Center at Mount Zion
Mar 21, 2022
Chronic Migraine Trial in Brookline (Emgality 120 MG in 1 ML Prefilled Syringe)
Recruiting
- Chronic Migraine
- Emgality 120 MG in 1 ML Prefilled Syringe
-
Brookline, MassachusettsPain Clinic at Beth Israel Deaconess Medical Center
Mar 16, 2022
Dry Eye, Asthenopia Trial in Torrance (Galcanezumab-gnlm, Ubrogepant)
Recruiting
- Dry Eye
- Asthenopia
-
Torrance, CaliforniaNVision-EWEI-Torrance
May 31, 2023
Healthy Trial in Shanghai (Galcanezumab, Placebo)
Completed
- Healthy
- Galcanezumab
- Placebo
-
Shanghai, Shanghai, ChinaHuaShan Hospital Affiliated To Fudan University
May 20, 2021
Safety, and Tolerability of GAlcanezumab in Real Life Migraine
Recruiting
- Migraine
- Galcanezumab
-
Rome, RM, ItalyCampus Bio Medico University Hospital
Mar 16, 2021
Episodic Migraine Trial in China, India, Russian Federation (Galcanezumab, Placebo)
Completed
- Episodic Migraine
- Galcanezumab
- Placebo
-
Beijing, Beijing, China
- +39 more
Jul 27, 2022
CGRP Inhibition, Autonomic Function, and Migraine
Recruiting
- Episodic Migraine
- Chronic Migraine
- Erenumab
- +2 more
-
Vienna, AustriaMedical University of Vienna
Apr 8, 2022
Episodic Cluster Headache, Chronic Cluster Headache Trial in Worldwide (Galcanezumab)
Completed
- Episodic Cluster Headache
- Chronic Cluster Headache
- Galcanezumab
-
Phoenix, Arizona
- +39 more
Jan 20, 2022
Migraine, Episodic Migraine Trial in United States (Galcanezumab, Placebo, Rimegepant)
Recruiting
- Migraine
- Episodic Migraine
- Galcanezumab
- +2 more
-
Gilbert, Arizona
- +75 more
Jan 16, 2023
Chronic Migraine Trial in Worldwide (Galcanezumab, Placebo)
Recruiting
- Chronic Migraine
- Galcanezumab
- Placebo
-
Huntsville, Alabama
- +82 more
Dec 26, 2022
Episodic Migraine Trial in Worldwide (Galcanezumab, Placebo)
Recruiting
- Episodic Migraine
- Galcanezumab
- Placebo
-
Huntsville, Alabama
- +76 more
Aug 17, 2022
Chronic Migraine, Headache Trial in Chicago (Combination of Botox + CGRPmAb (Fremanezumab 225mg/1.5mL))
Recruiting
- Chronic Migraine, Headache
- Combination of Botox + CGRPmAb (Fremanezumab 225mg/1.5mL)
-
Chicago, IllinoisChicago Headache Center & Research Institute
Feb 2, 2023
Monoclonal Antibody Duration of REsponse in MIgraine After
Recruiting
- Migraine
- Headache, Migraine
- Headache calendar completion
-
Valladolid, SpainHospital Clínico Universitario de Valladolid
Jul 15, 2022